Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
December 17, 2021 08:16 ET
|
Vir Biotechnology, Inc.
LONDON and SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the European Commission (EC) has...
CAPPEM fully supports OHA directives to fight Omicron
December 16, 2021 17:30 ET
|
Canadian Association of PPE Manufacturers
CAMBRIDGE, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- With the high level of uncertainty over the effects of the newest COVID-19 variant Omicron, the Canadian Association of PPE Manufacturers...
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Tablet Vaccine Against Omicron
December 16, 2021 08:00 ET
|
Vaxart, Inc.
Cross-reactivity will be assessed using samples from Phase II clinical participants and in a parallel animal challenge study Oral tablet’s immunogenicity profile suggests it may provide...
SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro
December 16, 2021 06:00 ET
|
SAB Biotherapeutics, Inc.
FDA laboratory testing confirms SAB-185 neutralizes Omicronand other variants of concern with in vitro pseudovirus model SAB’s targeted, highly potent and fully-human polyclonal antibodies continue...
Bielcor Launches 2 Day Free Shipping of N95 Masks Ahead of Omicron Variant
December 15, 2021 09:00 ET
|
Bielcor
Glendale, Arizona, Dec. 15, 2021 (GLOBE NEWSWIRE) -- As of December 2021, NIOSH-approved N95 mask supplier Bielcor has begun offering free two-day shipping on orders directly through its website. ...
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its Effect on the Neutralizing Activity of Monoclonal Antibodies, Convalescent Antibodies and Vaccine-Elicited Antibodies
December 14, 2021 16:40 ET
|
Vir Biotechnology, Inc.
– Data demonstrate sotrovimab, developed by Vir in conjunction with GlaxoSmithKline, continues to retain in vitro neutralizing activity against all tested variants of concern, including Omicron – SAN...
Aalto Bio Reagents announces SARS nCOV 2 NP and Mabs for Omicron Variant
December 13, 2021 09:00 ET
|
Aalto Bio Reagents Ltd
DUBLIN, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Aalto Bio Reagents ltd., a leading developer of critical raw materials and reagents for the development of diagnostic tests globally, announced today that...
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders
December 13, 2021 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 13, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma Names Brian Feagan, M.D., to Scientific Advisory Board
December 09, 2021 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 09, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Press release Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant
December 09, 2021 01:00 ET
|
Biocartis NV
PRESS RELEASE: 9 December 2021, 07:00 CET Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant Mechelen, Belgium, 9 December 2021 – Biocartis Group NV (the ‘Company’ or...